This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Warner, E. Articles by Narod, S. A. Search for Related Content PubMed PubMed Citation Articles by Warner, E. Articles by Narod, S. A. Social Bookmarking                            What's this?

Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer

From the Divisions of Medical and Preventive Oncology, Departments of Medical Biophysics, Medical Imaging, Pathology, and Surgery, and Centre for Research in Women’s Health, Sunnybrook and Women’s College Health Sciences Centre; Department of Clinical Biochemistry, Toronto Hospital; and Department of Health Administration, University of Toronto, Toronto, Ontario, Canada.

Address reprint requests to Ellen Warner, MD, Division of Medical Oncology, Toronto Sunnybrook Regional Cancer Centre, 2075 Bayview Ave, Toronto, Ontario M4N 3M5, Canada; email: ellen.warner{at}tsrcc.on.ca

PURPOSE: Recommended surveillance for BRCA1 and BRCA2 mutation carriers includes regular mammography and clinical breast examination, although the effectiveness of these screening techniques in mutation carriers has not been established. The purpose of the present study was to compare breast magnetic resonance imaging (MRI) with ultrasound, mammography, and physical examination in women at high risk for hereditary breast cancer.

PATIENTS AND METHODS: A total of 196 women, aged 26 to 59 years, with proven BRCA1 or BRCA2 mutations or strong family histories of breast or ovarian cancer underwent mammography, ultrasound, MRI, and clinical breast examination on a single day. A biopsy was performed when any of the four investigations was judged to be suspicious for malignancy.

RESULTS: Six invasive breast cancers and one noninvasive breast cancer were detected among the 196 high-risk women. Five of the invasive cancers occurred in mutation carriers, and the sixth occurred in a woman with a previous history of breast cancer. The prevalence of invasive or noninvasive breast cancer in the 96 mutation carriers was 6.2%. All six invasive cancers were detected by MRI, all were 1.0 cm or less in diameter, and all were node-negative. In contrast, only three invasive cancers were detected by ultrasound, two by mammography, and two by physical examination. The addition of MRI to the more commonly available triad of mammography, ultrasound, and breast examination identified two additional invasive breast cancers that would otherwise have been missed.

CONCLUSION: Breast MRI may be superior to mammography and ultrasound for the screening of women at high risk for hereditary breast cancer.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				W. D. Foulkes Inherited Susceptibility to Common Cancers N. Engl. J. Med., November 13, 2008; 359(20): 2143 - 2153. [Full Text] [PDF]

				E. Warner, H. Messersmith, P. Causer, A. Eisen, R. Shumak, and D. Plewes Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer Ann Intern Med, May 6, 2008; 148(9): 671 - 679. [Abstract] [Full Text] [PDF]

				R. Z. Bigenwald, E. Warner, A. Gunasekara, K. A. Hill, P. A. Causer, S. J. Messner, A. Eisen, D. B. Plewes, S. A. Narod, L. Zhang, et al. Is Mammography Adequate for Screening Women with Inherited BRCA Mutations and Low Breast Density? Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 706 - 711. [Abstract] [Full Text] [PDF]

				J. M. Lee, D. B. Kopans, P. M. McMahon, E. F. Halpern, P. D. Ryan, M. C. Weinstein, and G. S. Gazelle Breast Cancer Screening in BRCA1 Mutation Carriers: Effectiveness of MR Imaging--Markov Monte Carlo Decision Analysis Radiology, March 1, 2008; 246(3): 763 - 771. [Abstract] [Full Text] [PDF]

				S. Schrading and C. K. Kuhl Mammographic, US, and MR Imaging Phenotypes of Familial Breast Cancer Radiology, January 1, 2008; 246(1): 58 - 70. [Abstract] [Full Text] [PDF]

				S. H. Javid, J. W. Carlson, J. E. Garber, R. L. Birdwell, S. Lester, S. Lipsitz, and M. Golshan Breast MRI Wire-Guided Excisional Biopsy: Specimen Size as Compared to Mammogram Wire-Guided Excisional Biopsy and Implications for Use. Ann. Surg. Oncol., December 1, 2007; 14(12): 3352 - 3358. [Abstract] [Full Text] [PDF]

				C. K. Kuhl Current Status of Breast MR Imaging * Part 2. Clinical Applications Radiology, September 1, 2007; 244(3): 672 - 691. [Abstract] [Full Text] [PDF]

				C. Kuhl The Current Status of Breast MR Imaging * Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice Radiology, August 1, 2007; 244(2): 356 - 378. [Abstract] [Full Text] [PDF]

				F. Pediconi, C. Catalano, A. Roselli, S. Padula, F. Altomari, E. Moriconi, A. M. Pronio, M. A. Kirchin, and R. Passariello Contrast-enhanced MR Mammography for Evaluation of the Contralateral Breast in Patients with Diagnosed Unilateral Breast Cancer or High-Risk Lesions Radiology, June 1, 2007; 243(3): 670 - 680. [Abstract] [Full Text] [PDF]

				L. Moy, F. Ponzo, M. E. Noz, G. Q. Maguire Jr., A. D. Murphy-Walcott, A. E. Deans, M. T. Kitazono, L. Travascio, and E. L. Kramer Improving Specificity of Breast MRI Using Prone PET and Fused MRI and PET 3D Volume Datasets J. Nucl. Med., April 1, 2007; 48(4): 528 - 537. [Abstract] [Full Text] [PDF]

				V. G. Vogel Identifying and Screening Patients at Risk of Second Cancers Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2027 - 2032. [Abstract] [Full Text] [PDF]

				P. A. Causer, C. A. Piron, R. A. Jong, B. N. Curpen, C. A. Luginbuhl, J. E. Glazier, E. Warner, K. Hill, J. Muldoon, G. Taylor, et al. MR Imaging-guided Breast Localization System with Medial or Lateral Access Radiology, August 1, 2006; 240(2): 369 - 379. [Abstract] [Full Text] [PDF]

				A. Bradbury and O. I. Olopade The Case for Individualized Screening Recommendations for Breast Cancer J. Clin. Oncol., July 20, 2006; 24(21): 3328 - 3330. [Full Text] [PDF]

				G J Heyes, A J Mill, and M W Charles Enhanced biological effectiveness of low energy X-rays and implications for the UK breast screening programme. Br. J. Radiol., March 1, 2006; 79(939): 195 - 200. [Abstract] [Full Text] [PDF]

				C. L. Buchanan, E. A. Morris, P. L. Dorn, P. I. Borgen, and K. J. Van Zee Utility of Breast Magnetic Resonance Imaging in Patients With Occult Primary Breast Cancer Ann. Surg. Oncol., December 1, 2005; 12(12): 1045 - 1053. [Abstract] [Full Text] [PDF]

				F. Pediconi, C. Catalano, R. Occhiato, F. Venditti, F. Fraioli, A. Napoli, M. A. Kirchin, and R. Passariello Breast Lesion Detection and Characterization at Contrast-enhanced MR Mammography: Gadobenate Dimeglumine versus Gadopentetate Dimeglumine Radiology, October 1, 2005; 237(1): 45 - 56. [Abstract] [Full Text] [PDF]

				C. K. Kuhl, H. H. Schild, and N. Morakkabati Dynamic Bilateral Contrast-enhanced MR Imaging of the Breast: Trade-off between Spatial and Temporal Resolution Radiology, September 1, 2005; 236(3): 789 - 800. [Abstract] [Full Text] [PDF]

				S. Meisamy, P. J. Bolan, E. H. Baker, M. G. Pollema, C. T. Le, F. Kelcz, M. C. Lechner, B. A. Luikens, R. A. Carlson, K. R. Brandt, et al. Adding in Vivo Quantitative 1H MR Spectroscopy to Improve Diagnostic Accuracy of Breast MR Imaging: Preliminary Results of Observer Performance Study at 4.0 T Radiology, August 1, 2005; 236(2): 465 - 475. [Abstract] [Full Text] [PDF]

				C. D. Lehman, E. R. DePeri, S. Peacock, M. D. McDonough, W. B. DeMartini, and J. Shook Clinical Experience with MRI-Guided Vacuum-Assisted Breast Biopsy Am. J. Roentgenol., June 1, 2005; 184(6): 1782 - 1787. [Abstract] [Full Text] [PDF]

				A. W. Kurian, M. A. Mills, M. Jaffee, B. M. Sigal, N. M. Chun, K. E. Kingham, L. C. Collins, K. W. Nowels, S. K. Plevritis, J. E. Garber, et al. Ductal Lavage of Fluid-Yielding and Non-Fluid-Yielding Ducts in BRCA1 and BRCA2 Mutation Carriers and Other Women at High Inherited Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1082 - 1089. [Abstract] [Full Text] [PDF]

				L. Esserman Integration of Imaging in the Management of Breast Cancer J. Clin. Oncol., March 10, 2005; 23(8): 1601 - 1602. [Full Text] [PDF]

				J. G. Elmore, K. Armstrong, C. D. Lehman, and S. W. Fletcher Screening for Breast Cancer JAMA, March 9, 2005; 293(10): 1245 - 1256. [Abstract] [Full Text] [PDF]

				E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer Am. J. Roentgenol., March 1, 2005; 184(3): 868 - 877. [Abstract] [Full Text] [PDF]

				E. E. Deurloo, S. H. Muller, J. L. Peterse, A. P. E. Besnard, and K. G. A. Gilhuijs Clinically and Mammographically Occult Breast Lesions on MR Images: Potential Effect of Computerized Assessment on Clinical Reading Radiology, March 1, 2005; 234(3): 693 - 701. [Abstract] [Full Text] [PDF]

				E. Warner, D. B. Plewes, K. A. Hill, P. A. Causer, J. T. Zubovits, R. A. Jong, M. R. Cutrara, G. DeBoer, M. J. Yaffe, S. J. Messner, et al. Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination JAMA, September 15, 2004; 292(11): 1317 - 1325. [Abstract] [Full Text] [PDF]

				M. E. Robson and K. Offit Breast MRI for Women With Hereditary Cancer Risk JAMA, September 15, 2004; 292(11): 1368 - 1370. [Full Text] [PDF]

				M. Kriege, C. T.M. Brekelmans, C. Boetes, P. E. Besnard, H. M. Zonderland, I. M. Obdeijn, R. A. Manoliu, T. Kok, H. Peterse, M. M.A. Tilanus-Linthorst, et al. Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition N. Engl. J. Med., July 29, 2004; 351(5): 427 - 437. [Abstract] [Full Text] [PDF]

				L. Liberman Breast Cancer Screening with MRI -- What Are the Data for Patients at High Risk? N. Engl. J. Med., July 29, 2004; 351(5): 497 - 500. [Full Text] [PDF]

				J. E. Garber and A.-R. Hartman Prophylactic Oophorectomy and Hormone Replacement Therapy: Protection at What Price? J. Clin. Oncol., March 15, 2004; 22(6): 978 - 980. [Full Text] [PDF]

				S. Narod and J. Lubinski Re: Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease J Natl Cancer Inst, October 15, 2003; 95(20): 1552 - 1552. [Full Text] [PDF]

				E. A. Morris, L. Liberman, D. J. Ballon, M. Robson, A. F. Abramson, A. Heerdt, and D. D. Dershaw MRI of Occult Breast Carcinoma in a High-Risk Population Am. J. Roentgenol., September 1, 2003; 181(3): 619 - 626. [Abstract] [Full Text] [PDF]

				M. V. Knopp, M. W. Bourne, F. Sardanelli, M. N. Wasser, L. Bonomo, C. Boetes, M. Muller-Schimpfle, M. A. Hall-Craggs, B. Hamm, A. Orlacchio, et al. Gadobenate Dimeglumine-Enhanced MRI of the Breast: Analysis of Dose Response and Comparison with Gadopentetate Dimeglumine Am. J. Roentgenol., September 1, 2003; 181(3): 663 - 676. [Abstract] [Full Text] [PDF]

				R. A. Jong, M. J. Yaffe, M. Skarpathiotakis, R. S. Shumak, N. M. Danjoux, A. Gunesekara, and D. B. Plewes Contrast-enhanced Digital Mammography: Initial Clinical Experience Radiology, September 1, 2003; 228(3): 842 - 850. [Abstract] [Full Text] [PDF]

				R. Wooster and B. L. Weber Breast and Ovarian Cancer N. Engl. J. Med., June 5, 2003; 348(23): 2339 - 2347. [Full Text] [PDF]

				H. Meijers-Heijboer, C. T.M. Brekelmans, M. Menke-Pluymers, C. Seynaeve, A. Baalbergen, C. Burger, E. Crepin, A. W.M. van den Ouweland, B. van Geel, and J. G.M. Klijn Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation J. Clin. Oncol., May 1, 2003; 21(9): 1675 - 1681. [Abstract] [Full Text] [PDF]

				R. A. Smith, D. Saslow, K. Andrews Sawyer, W. Burke, M. E. Costanza, W. P. Evans III, R. S. Foster Jr., E. Hendrick, H. J. Eyre, and S. Sener American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 CA Cancer J Clin, May 1, 2003; 53(3): 141 - 169. [Abstract] [Full Text] [PDF]

				W. A. Berg Rationale for a Trial of Screening Breast Ultrasound: American College of Radiology Imaging Network (ACRIN) 6666 Am. J. Roentgenol., May 1, 2003; 180(5): 1225 - 1228. [Full Text] [PDF]

				L. Liberman, E. A. Morris, D. D. Dershaw, A. F. Abramson, and L. K. Tan MR Imaging of the Ipsilateral Breast in Women with Percutaneously Proven Breast Cancer Am. J. Roentgenol., April 1, 2003; 180(4): 901 - 910. [Abstract] [Full Text] [PDF]

				L. Liberman, E. A. Morris, C. M. Kim, J. B. Kaplan, A. F. Abramson, J. H. Menell, K. J. Van Zee, and D. D. Dershaw MR Imaging Findings in the Contralateral Breast of Women with Recently Diagnosed Breast Cancer Am. J. Roentgenol., February 1, 2003; 180(2): 333 - 341. [Abstract] [Full Text] [PDF]

				D G R Evans and F Lalloo Risk assessment and management of high risk familial breast cancer J. Med. Genet., December 1, 2002; 39(12): 865 - 871. [Abstract] [Full Text] [PDF]

				R. Katz-Brull, P. T. Lavin, and R. E. Lenkinski Clinical Utility of Proton Magnetic Resonance Spectroscopy in Characterizing Breast Lesions J Natl Cancer Inst, August 21, 2002; 94(16): 1197 - 1203. [Abstract] [Full Text] [PDF]

				M. S. van Roosmalen, L. C.G. Verhoef, P. F.M. Stalmeier, N. Hoogerbrugge, and W. A.J. van Daal Decision Analysis of Prophylactic Surgery or Screening for BRCA1 Mutation Carriers: A More Prominent Role For Oophorectomy J. Clin. Oncol., April 15, 2002; 20(8): 2092 - 2100. [Abstract] [Full Text] [PDF]

				L. Scheuer, N. Kauff, M. Robson, B. Kelly, R. Barakat, J. Satagopan, N. Ellis, M. Hensley, J. Boyd, P. Borgen, et al. Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers J. Clin. Oncol., March 1, 2002; 20(5): 1260 - 1268. [Abstract] [Full Text] [PDF]

				J. Goffin, P. O. Chappuis, N. Wong, and W. D. Foulkes Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer J Natl Cancer Inst, November 21, 2001; 93(22): 1754 - 1754. [Full Text] [PDF]

				M. J. Stoutjesdijk, C. Boetes, and J. O. Barentsz RESPONSE: Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer J Natl Cancer Inst, November 21, 2001; 93(22): 1755 - 1755. [Full Text] [PDF]

				S. Narod, K. Offit, M. Robson, D. Schrag, T. Riggs, M. J. Stoutjesdijk, J. O. Barentsz, J. G.M. Klijn, and H. Meijers-Heijboer Prophylactic Mastectomy in Carriers of BRCA Mutations N. Engl. J. Med., November 15, 2001; 345(20): 1498 - 1500. [Full Text] [PDF]